The Niche Stem Cell & Regen Med Website

We have a new post today!

Weekly reads: human CRISPR, MRT risks, private IRBs, skincare

It's funny how sometimes there are many new articles about one general topic like this week with heritable (and somatic) human CRISPR gene editing and related tech.  There are clear reasons for optimism in the somatic arena given advancing trials. Germline editing remains highly questionable in my view even just technically. Then there are loads of ethical issues. On a …
David Liu, human CRISPR